DelveInsight has launched new reports: Post-Surgical Pain Market, Idiopathic Membranous Nephropathy Market, Post Menopausal Osteoporosis Market, Atrial Flutter Market and Xerostomia Market
The Post-Surgical
Pain market report provides current treatment practices, emerging
drugs, Post-Surgical Pain market share of the individual therapies, current and
forecasted Post-Surgical Pain market Size from 2017 to 2030 segmented by seven
major markets. The Report also covers current Post-Surgical Pain treatment
practice/algorithm, market drivers, market barriers and unmet medical needs to
curate best of the opportunities and assesses the underlying potential of the
market.
Post-Surgical
Pain Drugs covered
1. Olinvo
(Oliceridine injection or TRV130)
2. HTX011
3.
CR845/Difelikefalin
4. NTM001
5.
PF05089771
And many
others
The key players in Post-Surgical
Pain market are:
1. Trevena
2. Heron
Therapeutics
3. Cara
Therapeutics
4.
Neumentum Pharmaceuticals
5. Pfizer
And many
others
View Report: https://www.delveinsight.com/report-store/post-surgical-pain-market
Idiopathic
Membranous Nephropathy Market
The Idiopathic
Membranous Nephropathy market report provides current treatment
practices, emerging drugs, Idiopathic Membranous Nephropathy market share of
the individual therapies, current and forecasted Idiopathic Membranous
Nephropathy market Size from 2017 to 2030 segmented by seven major markets. The
Report also covers current Idiopathic Membranous Nephropathy treatment
practice/algorithm, market drivers, market barriers and unmet medical needs to
curate best of the opportunities and assesses the underlying potential of the
market.
Idiopathic
Membranous Nephropathy Drugs covered
1. Olinvo
(Oliceridine injection or TRV130)
2. HTX011
3.
CR845/Difelikefalin
4. NTM001
5.
PF05089771
And many
others
The key players in Idiopathic
Membranous Nephropathy market are:
1. Trevena
2. Heron
Therapeutics
3. Cara
Therapeutics
4.
Neumentum Pharmaceuticals
5. Pfizer
And many
others
View Report: https://www.delveinsight.com/report-store/idiopathic-membranous-nephropathy-market
Post
Menopausal Osteoporosis Market
The Post
Menopausal Osteoporosis market report provides current treatment
practices, emerging drugs, Post Menopausal Osteoporosis market share of the
individual therapies, current and forecasted Post Menopausal Osteoporosis market
Size from 2017 to 2030 segmented by seven major markets. The Report also covers
current Post Menopausal Osteoporosis treatment practice/algorithm, market
drivers, market barriers and unmet medical needs to curate best of the
opportunities and assesses the underlying potential of the market.
The key players in Post
Menopausal Osteoporosis market are:
1. Trevena
2. Heron
Therapeutics
3. Cara
Therapeutics
4.
Neumentum Pharmaceuticals
5. Pfizer
And many
others
View Report: https://www.delveinsight.com/report-store/post-menopausal-osteoporosis-market
Atrial
Flutter Market: Trends and Opportunities
Increase in the number of people with various common
diseases like obesity and diabetes are anticipated to fuel the world market for
atrial
flutter over the period of forecast. Rise in the prevalence of many
different types of heart diseases like stroke, heart attack, and congestive
heart failure are also anticipated to propel the said market. In accordance
with the World Health Organization, cardiovascular diseases have been the
leading cause of death across the globe. More people die every year from
cardiovascular diseases than from any other type of disease. Cardiovascular
diseases have been responsible for around 17.7 million deaths in the year 2015,
thereby representing around 31% of the total deaths across the globe. Out of
all of these deaths, around 7.4 million were owing to coronary heart disease
and 6.7 million owing to stroke.
View Report: https://www.delveinsight.com/report-store/atrial-flutter-market
Xerostomia is defined as the
“complaint of oral dryness”. It can occur due to inadequate salivary secretion secondary
to abnormal function of the salivary glands, which is categorized as “true”
xerostomia; however, most patients with xerostomia often do not have objective
signs of hypo salivation. “Symptomatic” xerostomia or “pseudo” xerostomia
refers to oral dryness despite normal salivary gland function.
Patients with xerostomia can
have clinical manifestations of difficulty in swallowing, chewing, and/orspeaking
and can present with burning mouth, halitosis, altered taste, dry buccal
mucosa, glossitis, cracked and peeled lips, oral candidiasis, and dental caries
despite good oral hygiene.
The causes of xerostomia
may be divided into two broad categories: systemic diseases and local factors.
Systemic diseases that can
cause xerostomia include, but are not limited to, endocrine, autoimmune, infectious,
and granulomatous diseases. The more common systemic diseases are reviewed
here. Local factors that can cause xerostomia include medications, head and
neck radiation therapy, and lifestyle factors.
Xerostomia occurs in 5.5% to
46% of the population, and most commonly in older adults.
View Report: https://www.delveinsight.com/report-store/xerostomia-market
Comments
Post a Comment